CLOS
VNDA icon

Compagnie Lombard Odier SCmA’s Vanda Pharmaceuticals VNDA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$1K – 575
2020
Q2 		$1K Hold
100
– – ﹤0.01% 522
2020
Q1 		$1K Hold
100
– – ﹤0.01% 495
2019
Q4 		$2K Hold
100
– – ﹤0.01% 503
2019
Q3 		$1K Hold
100
– – ﹤0.01% 522
2019
Q2 		$1K Hold
100
– – ﹤0.01% 518
2019
Q1 		$2K Buy
+100
New +$2.28K ﹤0.01% 558

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Compagnie Lombard Odier SCmA's VNDA Position: Q3 2020 in Review

Compagnie Lombard Odier SCmA sold out of Vanda Pharmaceuticals (VNDA) in Q3 2020, closing a stake of 100 shares — an estimated $1K sold.

Compagnie Lombard Odier SCmA first reported a position in VNDA in Q1 2019 and held it in 6 quarters. The position peaked at $2K in Q4 2019. 164 funds tracked by Wall St. Rank hold VNDA as of Q3 2020.

  • Compagnie Lombard Odier SCmA reported no remaining Vanda Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 100 Vanda Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Compagnie Lombard Odier SCmA first reported a position in Vanda Pharmaceuticals in Q1 2019 and held it in 6 quarters.
  • Compagnie Lombard Odier SCmA's Vanda Pharmaceuticals position peaked at $2K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2020, filed 12 Nov 2020.